<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">KETOCONAZOLE</span><br/>(ke-to-con'a-zol)<br/><span class="topboxtradename">Nizoral, </span><span class="topboxtradename">Nizoral AD<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">azole antifungal</span><br/><b>Prototype: </b>Fluconazole<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>200 mg tablets; 2% cream; 2% shampoo</p>
<h1><a name="action">Actions</a></h1>
<p>Fungistatic; may also be fungicidal depending on concentration. Interferes with formation of ergosterol, the principal sterol
         in the fungal cell membrane that, when depleted, interrupts membrane function.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Antifungal properties are related to the drug effect on the fungal cell membrane functioning.</p>
<h1><a name="uses">Uses</a></h1>
<p>
<b>Oral</b>Severe systemic fungal infections including candidiasis (e.g., oral thrush, candiduria), chronic mucocutaneous candidiasis,
         pulmonary and disseminated coccidioidomycosis, histoplasmosis, paracoccidioidomycosis, blastomycosis, and chromomycosis. <b>Topical</b>Tinea corporis and tinea cruris (caused by <i>Epidermophyton floccosum, Trichophyton mentagrophytes,</i> and <i>Trichophyton rubrum</i>) and in treatment of tinea versicolor (pityriasis) caused by <i>Malassezia furfur (Pityrosporum obiculare),</i> seborrheic dermatitis.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>
<b>Oral</b>Onychomycosis, vaginal candidiasis, Cushing's syndrome associated with adrenal or pituitary adenoma; precocious puberty, dysfunctional
         hirsutism, and as swish and swallow preparation for prophylaxis against fungal infections in patients with neutropenia induced
         by cancer chemotherapy and in patients with AIDS.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to ketoconazole or any component in the formulation; chronic alcoholism, fungal meningitis; onychomycosis;
         ocular exposure, ophthalmic administration. Safety during pregnancy (category C), lactation, or in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Achlorhydria, hypochlorhydria; history of hepatic disease, HIV infection; alcoholism; azole antifungal hypersensitivity.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Fungal Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200400 mg once/d <span class="rdroute">Topical</span> Apply 12 times/d to affected area and surrounding skin<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>&gt;2 y,</i> 3.36.6 mg/kg/d as single dose<br/><br/><span class="indicationtitle">Dandruff</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Topical</span> Shampoo twice a week for 4 wk with at least 3 d between shampoos<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with water, fruit juice, coffee, or tea; drug requires an acid medium for dissolution and absorption.</li>
<li>Relieve nausea and vomiting during early therapy by taking drug with food and dividing into 2 daily doses.</li>
<li>Do not give with antacids.</li>
<li>Store in tightly covered container at 15°30° C (59°86° F) unless otherwise directed.</li>
</ul><span class="adminroutetype">Topical</span><br/><ul>
<li>Apply sufficient shampoo to produce lather to wash scalp and hair and gently massage over entire scalp area for 1 min, rinse
            hair thoroughly and repeat, leaving shampoo on scalp for 3 min. Rinse thoroughly.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">OralBody as a Whole:</span> Skin rash, erythema, urticaria, pruritus, angioedema, <span class="speceff-life">anaphylaxis</span>. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea, vomiting,</span> anorexia, epigastric or abdominal pain, constipation, diarrhea, transient elevation in serum liver enzymes, <span class="speceff-life">fatal hepatic necrosis</span> (rare). <span class="typehead">Hematologic:</span> With high doses, lowers serum testosterone and ACTH-induced corticosteroid serum levels, transient decreases in serum cholesterol
      and triglycerides; hyponatremia (rare). <span class="typehead">Urogenital:</span> Gynecomastia (males), breast pain; uterine bleeding, loss of libido, impotence, oligospermia, hair loss. <span class="typehead">Other:</span>
<span class="speceff-life">Acute hypoadrenalism (reduction of adrenal stress syndrome), renal hypofunction</span>. <span class="typehead">TopicalSkin:</span> Mild transient erythema, severe irritation, pruritus, stinging. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> may cause sunburnlike reaction; <span class="classification">antacids</span>, <span class="classification">anticholinergics</span>, <span class="classification">H<sub>2</sub>-receptor antagonists</span> decrease ketoconazole absorption; <b>isoniazid,</b>
<b>rifampin</b> increase ketoconazole metabolism, thus decreasing its activity; levels of <b>phenytoin</b> and ketoconazole decreased; may increase levels of <b>cyclosporine</b> or <b>carbamazepine</b>, increasing the risk of toxicity; <b>warfarin</b> may potentiate hypoprothrombinemia; may increase ergotamine toxicity of <b>dihydroergotamine,</b>
<b>ergotamine;</b> may increase concentration and toxicity of <b>trazodone.</b>
<span class="typehead">Herbal:</span>
<b>Echinacea</b> may increase risk of hepatotoxicity. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Erratically absorbed from GI tract (needs an acid pH); minimal absorption topically. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Distribution:</span> Distributed to saliva, urine, sebum, and cerumen; CSF levels unpredictable; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Primarily excreted in feces, 13% in urine. <span class="typehead">Half-Life:</span> 8 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Monitor baseline liver function tests (AST, ALT, alkaline phosphatase, and bilirubin) and repeat at least monthly
            throughout therapy.
         </li>
<li>Monitor for S&amp;S of hepatotoxicity (see Appendix F). Discontinue drug immediately to prevent irreversible liver damage and
            report to physician.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report S&amp;S of hepatotoxicity promptly to physician (see Appendix F).</li>
<li>
            							Note: Drowsiness and dizziness are early and time-limited adverse effects.
            						
         </li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Avoid OTC drugs for gastric distress, such as Rolaids, Tums, Alka-Seltzer and check with physician before taking any other
            nonprescribed medicines.
         </li>
<li>Do not alter dose or dose interval and do not stop taking ketoconazole before consulting the physician.</li>
<li>Notify physician if skin condition fails to respond to topical therapy or worsens or if signs of irritation or sensitivity
            occur.
         </li>
<li>Do not breast feed infants while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>